ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Please note that you are viewing an archived section from 2022 and some content may be unavailable. To unlock all content for 2022, please visit the archives.

Abstract: FR-PO886

Gender Disparity in CKD: Men From Mars, Women From Venus

Session Information

Category: Diversity and Equity in Kidney Health

  • 800 Diversity and Equity in Kidney Health

Authors

  • Sahay, Manisha, Osmania Medical College, Hyderabad, Telangana, India
  • Kumar, Vivek, Post Graduate Institute of Medical Education and Research, Chandigarh, Chandigarh, India
  • Kundu, Monica, The George Institute for Global Health, Newtown, New South Wales, Australia
  • Yadav, Ashok Kumar, Post Graduate Institute of Medical Education and Research, Chandigarh, Chandigarh, India
  • Jha, Vivekanand, The George Institute for Global Health, Newtown, New South Wales, Australia

Group or Team Name

  • ICKD study group
Background

There is no data on sex difference in CKD in developing countries. We examined sex differences in pan-country prospective, observational cohort study

Methods

We used data from 1331 women & 2725 men with eGFR 15–60 mL/min/1.73 m2 or >60 mL/min/1.73 m2 with proteinuria from different geographical regions & compared demographics, clinical profile, QOL & Outcomes-ESKD(CKD 5/chronic dialysis/kidney transplantation), 50% decline in eGFR & mortality

Results

Cause of CKD was DKD (24.9% in men, 25% in women), CIN (22.8% in men , 24% in women) and unknown 20% in men and 18.3% in women. Urine albumin, BMI, waist-hip ratio, LDL, Phosphours, PTH were higher in females while serum haemoglobin and calcium, use of iron,erythropoietin & statin were lower. SGA scores were similar. Men had better QOL.There was no significant difference in renal outcomes or mortality (Fig1,2)
Risk factors for mortality, 50% GFR decline, incident ESRD are shown in Table1

Conclusion

This largest CKD cohort study with detailed phenotyping, rigorous follow-up showed that Women have poor literacy, QOL.hemoglobin, lower iron, ESA, statin use. Risk of progression to ESKD & mortality slightly more in women.

Table 1 Risk factors for renal outcomes and all cause mortality
 MalesFemales
risk factor for all cause mortalityAge (HR = 1.03, p = 0.01), sedentary lifestyle (HR = 0.62, p = 0.04), history of renal stone (HR=0.45, p = 0.05), history of CVD (HR=2.04, p <0.01) and BMI (HR = 0.92, p = 0.01Age (HR = 1.04, p = 0.02)
Risk of =/>50% GFR decline Systolic BP (HR= 1.01, p = 0.01)
NSAID (HR= 2.14, p <0.01)
Age (HR= 0.97, p = 0.010, ABI, systolic bp (HR = 1.04, p < 0.01), diastolic bp (HR = 0.96, p ,0.01) and NSAID (HR = 2.14, p = 0.05).
Risk factors for incident ESRDage (HR = 0.98, p = 0.01), history of renal stones (HR = 0.54, p = 0.05), systolic BP (HR = 1.02, p <0.01)ABI, systolic bp (HR = 1.02, p =0.02) and history of renal stone (HR= 0.34, p = 0.05

Funding

  • Government Support – Non-U.S.